Finance

Lists
Why is EVMN down 2,81%?
Dive Deeper
EVMN:NYSE
Evommune Inc
US$5,88
-2,81%
(-0,17) 1D
US$5,80
-1,36% (-0,080)
After hours
Closed: 13 ຕ.ລ., 16 ໂມງ 0 ນາທີ 02 ວິນາທີ GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for EVMN...
Open
US$6,05
High
US$6,05
Low
US$5,85
Mkt. cap
213,40 ລ້ານ
Avg. vol.
895,76 ພັນ
Volume
805,29 ພັນ
52-wk high
US$33,20
52-wk low
US$5,85
EPS
US$-2,89
Shares outstanding
36,29 ລ້ານ
No. of employees
48
Open
US$6,05
High
US$6,05
Low
US$5,85
Mkt. cap
213,40 ລ້ານ
Avg. vol.
895,76 ພັນ
Volume
805,29 ພັນ
52-wk high
US$33,20
52-wk low
US$5,85
EPS
US$-2,89
Shares outstanding
36,29 ລ້ານ
No. of employees
48
News stories
From web sources and news partners
About Evommune Inc
CEO-
Employees48
Founded2020
HeadquartersPalo Alto, ແຄລິຟໍເນຍ, ສະຫະລັດ
SectorBiotechnology
Websiteevommune.com
Analyst ratings
Based on 13 analysts giving stock ratings to EVMN in the past 3 months
Strong buy
Buy
10
Hold
3
Sell
0
12-month forecast
Based on 13 Wall Street analysts offering 12 month price targets for EVMN in the last 3 months.
Highest
Current US$5,88
US$30,00 (+410,20%)
Average
US$22,40 (+280,95%)
Lowest
US$8,00 (+36,05%)
Analyst
Recommendation
Action
Price target
Projected
Date
Alice Nettleton
UBS
Hold
Initiated
US$8,00
+36,1%
10/12/2026
Unknown Analyst
UBS
Hold
Initiated
US$8,00
+36,1%
10/11/2026
Mitchell Kapoor
H.C. Wainwright
Hold
Reiterated
-
-
10/05/2026
Prakhar Agrawal
Cantor Fitzgerald
Buy
Maintained
-
-
09/17/2026
Kaveri Pohlman
Clear Street
Buy
Maintained
US$23,00
+291,2%
09/09/2026
Alex Thompson CFA
Stifel Nicolaus
Buy
Maintained
US$30,00
+410,2%
09/09/2026
Serge Belanger
Needham
Buy
Maintained
US$28,00
+376,2%
09/09/2026
Thomas Smith
Leerink Partners
Buy
Reiterated
US$22,00
+274,1%
09/10/2026
Martin Auster
Raymond James
Buy
Maintained
US$18,00
+206,1%
09/09/2026
Kostas Biliouris
Oppenheimer
Buy
Reiterated
US$26,00
+342,2%
09/09/2026
Brian Abrahams
RBC Capital
Buy
Maintained
US$21,00
+257,1%
09/08/2026
Matt Phipps
William Blair
Hold
Maintained
-
-
09/09/2026
Gavin Clark-Gartner
Evercore ISI
Buy
Maintained
US$22,00
+274,1%
08/10/2026
Judah Frommer
Morgan Stanley
Buy
Reiterated
US$26,00
+342,2%
08/10/2026
Last report
6 ສ.ຫ. 2026
Fiscal period
Q2 2026
US$-0,89 / US$-0,67
-32,84%miss
Revenue / Est. (USD)
- / 1,14 ລ້ານ
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ກ.ຍ. 2025
ທ.ວ. 2025
ມ.ນ. 2026
ມິ.ຖ. 2026
Revenue
10,00 ລ້ານ
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
19,64 ລ້ານ
20,40 ລ້ານ
17,32 ລ້ານ
26,41 ລ້ານ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,69 ລ້ານ
9,31 ລ້ານ
6,64 ລ້ານ
8,48 ລ້ານ
Operating expense
23,33 ລ້ານ
29,72 ລ້ານ
23,95 ລ້ານ
34,90 ລ້ານ
Total operating expenses
23,33 ລ້ານ
29,72 ລ້ານ
23,95 ລ້ານ
34,90 ລ້ານ
Operating income
-13,33 ລ້ານ
-29,72 ລ້ານ
-23,95 ລ້ານ
-34,90 ລ້ານ
Other non operating income
-9,00 ພັນ
-
-4,00 ພັນ
-2,00 ພັນ
EBT including unusual items
-12,48 ລ້ານ
-28,27 ລ້ານ
-21,67 ລ້ານ
-32,25 ລ້ານ
EBT excluding unusual items
-12,48 ລ້ານ
-28,27 ລ້ານ
-21,67 ລ້ານ
-32,25 ລ້ານ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-12,48 ລ້ານ
-28,27 ລ້ານ
-21,67 ລ້ານ
-32,25 ລ້ານ
Net profit margin
-124,75%
-
-
-
Earnings per share
-8,07
-1,43
-0,64
-0,89
Interest and investment income
862,00 ພັນ
1,44 ລ້ານ
2,28 ລ້ານ
2,65 ລ້ານ
Interest expense
-
-
-
-
Net interest expenses
862,00 ພັນ
1,44 ລ້ານ
2,28 ລ້ານ
2,65 ລ້ານ
Depreciation and amortization charges
-
-
-
-
EBITDA
-13,02 ລ້ານ
-29,39 ລ້ານ
-23,60 ລ້ານ
-34,34 ລ້ານ
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
ແອັບຂອງ Google